Simultaneous Double-Purging of Breast Cancer Cells from Leukapheresis Products by Immunomagnetic CD34+ Cell Enrichment and Tumor Cell Depletion

[1]  S. Braun,et al.  Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.

[2]  N. Schmitz,et al.  Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL , 1997, Bone Marrow Transplantation.

[3]  J. Armitage,et al.  High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Pedrazzoli,et al.  A new ‘two step’ procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation , 1997, Bone Marrow Transplantation.

[5]  B. Dörken,et al.  Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. , 1997, Blood.

[6]  E. Thiel,et al.  Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy. , 1996, Bone marrow transplantation.

[7]  G. Kvalheim.  Purging of autografts: methods and clinical significance. , 1996, Annals of medicine.

[8]  S. Heimfeld,et al.  Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. , 1994, Blood.

[9]  L. Kanz,et al.  Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments] , 1994 .

[10]  E. Shpall,et al.  Release of tumor cells from bone marrow. , 1994, Blood.

[11]  Rill,et al.  Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. , 1994, Blood.

[12]  N. Davidson,et al.  Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. , 1993, Blood.

[13]  W. Berdel,et al.  Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. , 1993, Cancer research.

[14]  W. Anderson,et al.  Gene-marking to trace origin of relapse after autologous bone-marrow transplantation , 1993, The Lancet.

[15]  J. Gribben,et al.  Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. , 1991, The New England journal of medicine.

[16]  R. Bast,et al.  Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. , 1991, Bone marrow transplantation.

[17]  G. Meloni,et al.  Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. , 1990, Blood.

[18]  R. Bast,et al.  Elimination of malignant clonogenic breast cancer cells from human bone marrow. , 1989, Cancer research.